Objectives-In sacrococcygeal teratoma, the presence of high-output cardiac failure resulting from arteriovenous shunting through the large tumor has been associated with an adverse outcome. The objective of this study was to determine whether the tumor size and cardiac biomarkers in cord blood can predict neonatal survival in sacrococcygeal teratoma.
S
acrococcygeal teratoma is the most common congenital neoplasm, with an incidence of 1 per 35,000 to 1 per 40,000 births. [1] [2] [3] [4] Before the introduction of universal prenatal ultrasound (US) screening, sacrococcygeal teratoma was often diagnosed after birth, and the prognosis of postnatally diagnosed sacrococcygeal teratoma depended on its malignant potential. 5 With the development of antenatal US, more than half of sacrococcygeal teratoma cases are now diagnosed in the antenatal period. 2 The reported mortality rate in the literature is approximately 30% to 50% for fetuses with sacrococcygeal teratoma. 6 Until now, there have been several studies on outcome prediction in antenatally diagnosed sacrococcygeal teratoma, but the results of these studies have not been consistent. Gestational age at the initial diagnosis, reasons for performing US examinations, placentomegaly, tumor morphologic characteristics, intrapelvic extension, and polyhydramnios have all been suggested as possible factors for outcome prediction. [6] [7] [8] Recently, a large tumor volume has been suggested as an important prognostic factor, in addition to other prognostic factors, including substantial vascularity and a large proportion of a solid component. 3, 5, 9 All of these prognostic factors suggest that cardiac overload from a high-output status can be the underlying pathophysiologic mechanism, and hydrops, which is the end stage of cardiac failure, is associated with the worst prognosis. 9 Considering this pathophysiologic mechanism, it is assumed that both tumor size and the biomarkers of heart failure may predict the neonatal outcome in sacrococcygeal teratoma. The objective of this study was to determine whether tumor size and the cardiac biomarkers for heart failure in cord blood can predict neonatal survival in antenatally diagnosed sacrococcygeal teratoma.
Materials and Methods

Study Design
In this retrospective cohort study, the study population consisted of neonates who were delivered with a diagnosis of sacrococcygeal teratoma at Seoul National University Hospital between March 1990 and January 2016. Sacrococcygeal teratoma was suspected on antenatal US examinations and confirmed by postnatal diagnosis. In most cases, the teratoma was confirmed by pathologic diagnosis, and the tumor was described pathologically as either a mature cystic teratoma or an immature teratoma.
The tumor size and cord blood concentrations of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) and cardiac troponin T (cTnT) were compared according to neonatal survival or death. Neonatal death was defined as death within the first 28 days of life. The Institutional Review Board of the Seoul National University Hospital approved the study.
Antenatal Ultrasound
Tumor size was measured in 2 or 3 dimensions by antenatal US. In cases in which only 2-dimensional measurement results were available, the third dimension of the tumor was calculated by applying the proportional expression that the tumor grows in parallel with the fetus. 10 Basically, the measured tumor size at diagnosis is to the estimated fetal weight at diagnosis what the size of the excised tumor mass after delivery is to the birth weight. Tumor volume was computed by the ellipsoid formula ([length 3 width 3 depth in cm] 3 0.52 5 volume in cm 3 ). To adjust gestational age, we used the tumor volume index, which was defined as the calculated tumor volume divided by the biparietal diameter ( Figure  1 ): tumor volume index 5 length 3 width 3 depth 3 0.52/biparietal diameter (cm 3 /cm). The US tumor morphologic types were divided into 5 grades depending on the solid and cystic features of the tumor, as follows: 1, completely cystic; 2, predominantly cystic; 3, evenly mixed; 4, predominantly solid; and 5, completely solid. 9 Tumor typing with regard to exophytic and endophytic features followed the classification guidelines of Altman et al. 11 They classified these tumors as type I, tumors predominantly external with only a minimal presacral component; type II, tumors presenting externally but with substantial intrapelvic extension; type III, tumors presenting externally, but the predominant mass is pelvic and extends into the abdomen; and type IV, tumors are presacral with no external presentation.
Hydrops was defined as the presence of fetal subcutaneous tissue edema accompanied by abnormal fluid collection in more than 1 area of the body.
Cord Blood Concentrations of NT-pro-BNP and cTnT
The cord blood was taken at the time of delivery, and the supernatant after centrifugation was stored at 2708C until assayed. The NT-pro-BNP and cTnT concentrations measured in stored cord blood by an electrochemiluminescence immunoassay (Cobas; Roche Diagnostics, Indianapolis, IN).
Statistical Analysis
Proportions were compared by the Fisher exact test, and comparisons of continuous variables between groups were performed by the Mann-Whitney U test. After adjustment for the presence of associated anomalies and gestational age at delivery, the association between the tumor volume index and neonatal death was assessed by multiple logistic regression with the Firth penalized likelihood to avoid bias in parameter estimates due to the small sample size. 12 The results were analyzed with SPSS version 20.0 software for Windows (IBM Corporation, Armonk, NY) and R, version 3.3.1 software (R Foundation for Statistical Computing, Vienna, Austria; http://www.r-project.org). P < .05 was considered significant.
Results
During the study period, a total of 27 neonates were delivered with a diagnosis of sacrococcygeal teratoma. After the exclusion of 1 case in which the tumor size by antenatal US was not documented in the medical record and 1 case in which the postnatal diagnosis was changed to meningomyelocele, the remaining 25 cases were included in the analysis.
Among the study population, the rate of neonatal death was 24% (6 of 25). Table 1 shows the clinical characteristics according to neonatal survival or death.
Cases with neonatal death delivered earlier than those with neonatal survival. However, maternal age, parity, neonatal sex, mode of delivery, and birth weight were not different between the groups. Table 2 compares the US findings according to neonatal survival or death. Cases with neonatal death had a higher tumor volume and tumor volume index. Receiver operating characteristic curves for prediction of neonatal death were generated to identify the best cutoff value for the tumor volume index, and a value of greater than 60 cm 3 /cm was designated as the cutoff value (Figure 2) . The sensitivity and specificity for prediction of /cm was associated with the risk of neonatal death even after adjustment for gestational age at delivery and the presence of associated anomalies (Table 3) .
In 19 cases (16 cases of neonatal survival and 3 cases of neonatal death), cord blood concentrations were available for measurement of NT-pro-BNP and cTnT. Cases with a tumor volume index of greater than 60 cm 3 /cm had higher concentrations of NT-pro-BNP and cTnT than those with a tumor volume index of less than 60 cm 3 /cm (NT-pro-BNP, 5737 versus 385 pg/mL; P < .05; cTnT, 0.18 versus 0.03 ng/mL; P < .005). Moreover, cases with neonatal death had higher concentrations of NT-pro-BNP and cTnT than those with survival. According to the receiver operating characteristic curves, an NT-pro-BNP concentration of greater than 2000 pg/mL and a cTnT concentration of greater than 0.08 ng/mL were designated as the cutoff values for prediction of neonatal death (Figure 3) . The sensitivity and specificity for prediction of neonatal death were 100% and 81.3% for NT-pro-BNP of greater than 2000 pg/mL and 100% and 100% for cTnT of greater than 0.08 ng/mL, respectively.
Discussion
The principal findings of the study were the following: (1) the rate of neonatal death in antenatally diagnosed sacrococcygeal teratoma was 24%; (2) cases with neonatal death had a higher tumor volume index and higher concentrations of NT-pro-BNP and cTnT than those with survival; (3) a tumor volume index of greater than 60 cm 3 /cm, elevated NT-pro-BNP (>2000 pg/ mL), and elevated cTnT (>0.08 ng/mL) had sensitivity of 100% for prediction of neonatal death.
The pathophysiologic process of perinatal death in antenatally diagnosed sacrococcygeal teratoma can be explained by 2 mechanisms. 9 The first mechanism is the mass effect of the tumor, associated polyhydramnios, or both, which can result in preterm labor and consequent preterm delivery with prematurity. However, the fact that the frequency of early preterm birth (<32 weeks) was only 17% in cases with neonatal death suggests that the preterm birth itself may not have been the major cause of neonatal death in this study. Another mechanism is the tumor vascular steal phenomenon, in which the tumor steals blood flow from the placenta and fetus, which can result in relative anemia and compensatory hypervolemia. Thus, high-output cardiac failure and hydrops occur frequently in succession.
It seems reasonable that the larger the tumor volume, the more likely the phenomenon of a vascular steal. However, the relationship between the tumor size and prognosis has not been reported consistently. 6, 9 This inconsistency might result from the fact that the tumor tends to grow according to the fetal growth. To overcome this problem, several studies have tried to adjust fetal size by using the fetal weight or head volume in sacrococcygeal teratoma. 1, [13] [14] [15] In this study, we created a value, the tumor volume index, and have shown that this 
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index was higher in cases with neonatal death. In addition, the relationship between the tumor volume index and neonatal death remained significant even after adjustment for other prognostic variables (gestational age at delivery and the presence of associated anomalies). At first, the abdominal circumference was tried for the formula instead of the biparietal diameter because the abdominal circumference has been known to reflect fetal weight better. However, in hydrops, we thought that the tumor volume-to-abdominal circumference ratio would be less useful because of the variability of the abdominal circumference measurement and consequent underestimation of the ratio (in cases of hydrops with ascites). Therefore, we used the biparietal diameter to adjust fetal size or gestational age at diagnosis. In addition to the tumor volume index, we have shown that the concentrations of NT-pro-BNP and cTnT were elevated in cases with neonatal death and in cases with a large tumor (tumor volume index >60 cm 3 /cm), even in the absence of hydrops. This finding suggests that the hypervolemic overloading may be present before the occurrence of hydrops, and might be used as an earlier marker than hydrops. N-terminal pro-BNP is a well-known biomarker for adult heart failure, and the concentration of NT-pro-BNP originating from ventricular myocytes is elevated because of myocardial stress/ stretch in response to a pressure or volume overload. [16] [17] [18] Cardiac TnT is used as a biomarker for myocardial injury, and its concentration is elevated during myocyte damage in decompensated heart failure, as well as during acute coronary disease. 19, 20 These biomarkers are also used in pediatric patients, and several studies have reported elevated concentrations of NT-pro-BNP and cTnT in heart failure or myocardial injury of pediatric patients. [21] [22] [23] [24] In fetuses, these biomarkers are elevated in cord blood of fetuses/neonates with congenital malformations associated with heart failure or cardiac damage. [25] [26] [27] [28] [29] [30] [31] [32] In addition, antenatal Doppler studies may help assess fetal cardiac dysfunction, and a pathologic change in venous blood flow was noted in sacrococcygeal teratoma in a previous report. 33 The association between cardiac biomarkers and antenatal Doppler studies needs to be determined in future studies.
Although we have shown the association between elevated concentrations of NT-pro-BNP and cTnT and the risk of neonatal death in sacrococcygeal teratoma, the clinical value of these cardiac biomarkers for outcome prediction may be limited by several factors. First, these markers are measured in cord blood at delivery, which cannot be used at the time of antenatal counseling. Second, these markers may not be independent predictive factors because heart failure and the increased sacrococcygeal teratoma volume share a similar pathogenesis.
In conclusion, the tumor volume index and elevated cord blood biomarkers for heart failure can predict neonatal death in sacrococcygeal teratoma.
